ARCTURUS THERAPEUTICS LTD's ticker is ARCT and the CUSIP is M1492T105. A total of 18 filers reported holding ARCTURUS THERAPEUTICS LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARK Investment Management | 533,773 | $4,526,000 | 0.17% |
| ROYCE & ASSOCIATES LP | 106,436 | $903,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 37,007 | $326,000 | 0.01% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 27,300 | $232,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 1,100 | $9,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,801 | $24,000 | 0.00% |
| 1832 Asset Management L.P. | 560 | $5,000 | 0.00% |
| CITIGROUP INC | 171 | $1,000 | 0.00% |
| BlackRock Inc. | 19,905 | $169,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 26,418 | $224,000 | 0.00% |